Follow
Lisa Welter
Title
Cited by
Cited by
Year
Tissue-infiltrating neutrophils constitute the major in vivo source of angiogenesis-inducing MMP-9 in the tumor microenvironment
EI Deryugina, E Zajac, A Juncker-Jensen, TA Kupriyanova, L Welter, ...
Neoplasia 16 (10), 771-788, 2014
2782014
Genomic cfDNA analysis of aqueous humor in retinoblastoma predicts eye salvage: The surrogate tumor biopsy for retinoblastoma
JL Berry, L Xu, I Kooi, AL Murphree, RK Prabakar, M Reid, K Stachelek, ...
Molecular Cancer Research 16 (11), 1701-1712, 2018
942018
Treatment response and tumor evolution: lessons from an extended series of multianalyte liquid biopsies in a metastatic breast cancer patient
L Welter, L Xu, D McKinley, AE Dago, RK Prabakar, S Restrepo-Vassalli, ...
Molecular Case Studies 6 (6), a005819, 2020
312020
Clonal diversity revealed by morphoproteomic and copy number profiles of single prostate cancer cells at diagnosis
PD Malihi, M Morikado, L Welter, ST Liu, ET Miller, RM Cadaneanu, ...
Convergent Science Physical Oncology 4 (1), 015003, 2018
242018
A new anion exchange purification method for Cu stable isotopes in blood samples
SC Yang, L Welter, A Kolatkar, J Nieva, KR Waitman, KF Huang, WH Liao, ...
Analytical and bioanalytical chemistry 411 (3), 765-776, 2019
212019
Preanalytical variables for the genomic assessment of the cellular and acellular fractions of the liquid biopsy in a cohort of breast cancer patients
SN Shishido, L Welter, M Rodriguez-Lee, A Kolatkar, L Xu, C Ruiz, ...
The Journal of Molecular Diagnostics 22 (3), 319-337, 2020
202020
Disease characterization in liquid biopsy from HER2-mutated, non-amplified metastatic breast cancer patients treated with neratinib
SN Shishido, R Masson, L Xu, L Welter, RK Prabakar, A D’Souza, ...
npj Breast Cancer 8 (1), 1-14, 2022
122022
A randomized trial of fulvestrant, everolimus and anastrozole for the front-line treatment of patients with advanced hormone receptor-positive breast cancer, SWOG S1222
HCF Moore, WE Barlow, G Somlo, JR Gralow, AF Schott, DF Hayes, ...
Clinical Cancer Research, 2021
62021
Circulating Tumor Cell Kinetics and Morphology from the Liquid Biopsy Predict Disease Progression in Patients with Metastatic Colorectal Cancer Following Resection
D Kolenčík, S Narayan, JA Thiele, D McKinley, AS Gerdtsson, L Welter, ...
Cancers 14 (3), 642, 2022
52022
Abstract: Genomic cfDNA analysis of aqueous humor in retinoblastoma (RB) predicts eye salvage
L Xu, JL Berry, I Kooi, AL Murphree, RK Prabakar, MW Reid, K Stachelek, ...
American Association for Cancer Research - Annual Meeting 79 (13 Supplement …, 2019
2*2019
Serum phosphatidylcholine is lower among breast cancer patients on systemic chemotherapy.
X Li, J Lim, A Kolatkar, L Welter, K Waitman, ESS Hwang, JM Lu, P Kuhn, ...
Journal of Clinical Oncology 35 (15_suppl), e12571-e12571, 2017
22017
Cell State and Cell Type: Deconvoluting Circulating Tumor Cell Populations in Liquid Biopsies by Multi-Omics
L Welter, S Zheng, SM Setayesh, M Morikado, A Agrawal, R Nevarez, ...
Cancers 15 (15), 3949, 2023
2023
Abstract: Morphologic and genomic characterization of circulating tumor cells in patients with ERBB2 mutant HER2 non-amplified metastatic breast cancer treated with neratinib
SN Shishido, R Masson, L Welter, L Xu, A D'Souza, D Spicer, J Hicks, ...
American Association for Cancer Research - Annual Meeting 79 (13 Supplement …, 2019
2019
Abstract P3-01-09: Tracing clonal evolution of circulating tumor cells and cell-free DNA in a metastatic breast cancer patient
L Welter, L Xu, D McKinley, AE Dago, S Restrepo-Vassalli, MR Lee, ...
San Antonio Breast Cancer Symposium 79 (4 Supplement), P3-01-09-P3-01-09, 2019
2019
Abstract: Integration of genomic analysis and assessment of pre-analytic variables in the HD-SCA workflow: A technical validation study
SN Shishido, M Rodriguez_Lee, A Kolatkar, L Xu, S Restrepo-Vassalli, ...
American Association for Cancer Research - Annual Meeting 78 (13 Supplement …, 2018
2018
Abstract: Characterization of disease evolution in sequential sampled metastatic breast cancer using liquid biopsy
L Welter, L Xu, D McKinley, S Restrepo-Vassalli, A Dago, MR Lee, ...
American Association for Cancer Research - Annual Meeting 78 (13 Supplement …, 2018
2018
Abstract: Circulating tumor cells and genomic profiling of patients with ERBB2 mutant, HER2 non-amplified metastatic breast cancer treated with neratinib.
A D'souza, S Shishedo, DV Spicer, L Welter, Y Jiang, DM Hyman, DB Solit, ...
American Society of Clinical Oncology 35 (15_suppl), e12554-e12554, 2017
2017
The system can't perform the operation now. Try again later.
Articles 1–17